| Issue Date | Title | Author(s) |
| 2018-11 | Mycobacterium marinum infection drives foam cell differentiation in zebrafish infection models. | Johansen, MD; Kasparian, JA; Hortle, E; Britton, WJ; Purdie, AC; Oehlers, SH |
| 2022-08 | The ESX-4 substrates, EsxU and EsxT, modulate Mycobacterium abscessus fitness. | Lagune, M; Le Moigne, V; Johansen, MD; Vásquez Sotomayor, F; Daher, W; Petit, C; Cosentino, G; Paulowski, L; Gutsmann, T; Wilmanns, M; Maurer, FP; Herrmann, J-L; Girard-Misguich, F; Kremer, L |
| 2022 | Exploring Macrophage-Dependent Wound Regeneration During Mycobacterial Infection in Zebrafish. | Bohaud, C; Johansen, MD; Varga, B; Contreras-Lopez, R; Barthelaix, A; Hamela, C; Sapède, D; Cloitre, T; Gergely, C; Jorgensen, C; Kremer, L; Djouad, F |
| 2022 | Virulence Mechanisms of Mycobacterium abscessus: Current Knowledge and Implications for Vaccine Design. | Ferrell, KC; Johansen, MD; Triccas, JA; Counoupas, C |
| 2022-02-17 | Rough and smooth variants of Mycobacterium abscessus are differentially controlled by host immunity during chronic infection of adult zebrafish. | Kam, JY; Hortle, E; Krogman, E; Warner, SE; Wright, K; Luo, K; Cheng, T; Manuneedhi Cholan, P; Kikuchi, K; Triccas, JA; Britton, WJ; Johansen, MD; Kremer, L; Oehlers, SH |
| 2022-05-19 | Glycopeptidolipid glycosylation controls surface properties and pathogenicity in Mycobacterium abscessus. | Daher, W; Leclercq, L-D; Johansen, MD; Hamela, C; Karam, J; Trivelli, X; Nigou, J; Guérardel, Y; Kremer, L |
| 2022-06 | Biochemical, structural, and functional studies reveal that MAB_4324c from Mycobacterium abscessus is an active tandem repeat N-acetyltransferase. | Alsarraf, HMAB; Ung, KL; Johansen, MD; Dimon, J; Olieric, V; Kremer, L; Blaise, M |
| 2022 | 1H-1,2,3-triazole embedded Isatin-Benzaldehyde-bis(heteronuclearhydrazones): design, synthesis, antimycobacterial, and cytotoxic evaluation. | Sharma, B; Kumar, S; Preeti,; Johansen, MD; Kremer, L; Kumar, V |
| 2023-07-20 | Publisher Correction: Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon | Ryan, TAJ; Hooftman, A; Rehill, AM; Johansen, MD; O' Brien, EC; Toller-Kawahisa, JE; Wilk, MM; Day, EA; Weiss, HJ; Sarvari, P; Vozza, EG; Schramm, F; Peace, CG; Zotta, A; Miemczyk, S; Nalkurthi, C; Hansbro, NG; McManus, G; O'Doherty, L; Gargan, S; Long, A; Dunne, J; Cheallaigh, CN; Conlon, N; Carty, M; Fallon, PG; Mills, KHG; Creagh, EM; O' Donnell, JS; Hertzog, PJ; Hansbro, PM; McLoughlin, RM; Wygrecka, M; Preston, RJS; Zasłona, Z; O'Neill, LAJ |
| 2023-06-14 | Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress Tissue Factor in macrophages via inhibition of Type I Interferon. | Ryan, TAJ; Hooftman, A; Rehill, AM; Johansen, MD; Brien, ECO; Toller-Kawahisa, JE; Wilk, MM; Day, EA; Weiss, HJ; Sarvari, P; Vozza, EG; Schramm, F; Peace, CG; Zotta, A; Miemczyk, S; Nalkurthi, C; Hansbro, NG; McManus, G; O'Doherty, L; Gargan, S; Long, A; Dunne, J; Cheallaigh, CN; Conlon, N; Carty, M; Fallon, PG; Mills, KHG; Creagh, EM; Donnell, JSO; Hertzog, PJ; Hansbro, PM; McLoughlin, RM; Wygrecka, M; Preston, RJS; Zasłona, Z; O'Neill, LAJ |
